Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Dean

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Current Opinion in Biotechnology|February 19, 2002
Functional genomics and target validation approaches using antisense oligonucleotide technologyN M Dean
Scottish Medical Journal|April 1, 1981
General practice in rural NorwayN M Dean
Health Bulletin|October 1, 1970
Personal points of view--the work of a District Doctor in Norway--some experiencesN M Dean
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 1976
[General practice in Nord-Trøndelag. Some observations]N M Dean
Drug News & Perspectives|June 14, 2003
Oligonucleotide inhibition of Fas as a potential treatment strategy in human liver diseaseH Zhang, N M Dean
Proceedings of the National Academy of Sciences of the United States of America|November 22, 1994
Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotidesN M Dean, R McKay
Trends in Pharmacological Sciences|January 19, 2000
Sensible use of antisense: how to use oligonucleotides as research toolsK J Myers, N M Dean
Current Opinion in Drug Discovery & Development|August 4, 2009
Regulation of pre-mRNA splicing by antisense oligonucleotidesJ K Taylor, N M Dean
The Biochemical Journal|July 15, 1990
Angiotensin II causes phosphatidylinositol turnover and increases 1,2-diacylglycerol mass but is not mitogenic in rat liver T51B cellsN M Dean, A L Boynton
The Biochemical Journal|March 1, 1987
Separation of multiple isomers of inositol phosphates formed in GH3 cellsN M Dean, J D Moyer
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Current Opinion in Biotechnology|February 19, 2002
Functional genomics and target validation approaches using antisense oligonucleotide technologyN M Dean
Scottish Medical Journal|April 1, 1981
General practice in rural NorwayN M Dean
Health Bulletin|October 1, 1970
Personal points of view--the work of a District Doctor in Norway--some experiencesN M Dean
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 20, 1976
[General practice in Nord-Trøndelag. Some observations]N M Dean
Drug News & Perspectives|June 14, 2003
Oligonucleotide inhibition of Fas as a potential treatment strategy in human liver diseaseH Zhang, N M Dean
Proceedings of the National Academy of Sciences of the United States of America|November 22, 1994
Inhibition of protein kinase C-alpha expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotidesN M Dean, R McKay
Trends in Pharmacological Sciences|January 19, 2000
Sensible use of antisense: how to use oligonucleotides as research toolsK J Myers, N M Dean
Current Opinion in Drug Discovery & Development|August 4, 2009
Regulation of pre-mRNA splicing by antisense oligonucleotidesJ K Taylor, N M Dean
The Biochemical Journal|July 15, 1990
Angiotensin II causes phosphatidylinositol turnover and increases 1,2-diacylglycerol mass but is not mitogenic in rat liver T51B cellsN M Dean, A L Boynton
The Biochemical Journal|March 1, 1987
Separation of multiple isomers of inositol phosphates formed in GH3 cellsN M Dean, J D Moyer
Pageof 8